GKOS, US3773221029

Mizuho lifts target for Glaukos stock to USD 190.00

Published on 10/15/2026 at 22:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Glaukos reports on October 28, 2026. Glaukos stock costs EUR 148.50 on October 15, 2026 at 9:48 p.m. CEST, down 1.20 percent on the NYSE.

Analyst view and trading details

  • Mizuho lifted its Glaukos target to USD 190.00 on October 13, 2026.
  • Glaukos is scheduled to report third-quarter results on October 28, 2026.
  • Glaukos stock costs EUR 148.50 at Lang & Schwarz on October 15, 2026 at 9:48 p.m. CEST, down 1.20 percent on the NYSE.
  • Glaukos has a USD 9.8 billion market capitalization and a price-to-earnings ratio of -51.10.
GKOS, US3773221029, Illustration mit AI erstellt.

Mizuho raised its price target for Glaukos from USD 185.00 to USD 190.00 on October 13, 2026, while maintaining an Outperform rating, according to Markets Insider. At 9:59 p.m. CEST, the NYSE quote stood at USD 165.87, down 1.20 percent from the previous close. The euro quote was EUR 148.50 at Lang & Schwarz on October 15, 2026 at 9:48 p.m. CEST.

Target distance reaches 14.55 percent

Mizuho's USD 190.00 target sits 14.55 percent above the NYSE price of USD 165.87. The target is therefore materially higher than the latest US listing quote, but it remains below the upper end of the current analyst range reported by other market coverage. This keeps the analyst view relevant without turning it into a forecast.

Price sits below yearly high

Glaukos traded between USD 165.36 and USD 170.12 during the October 15, 2026 NYSE session. Its 52-week range was USD 73.16 to USD 191.62, leaving the latest US quote 13.44 percent below the high. The distance gives the stock room below its yearly peak while placing it well above the lower end of the range.

Valuation and October 28 date

The company had a market capitalization of USD 9.8 billion and a price-to-earnings ratio of -51.10 as of October 15, 2026. The next scheduled company date is October 28, 2026, when Glaukos is due to report third-quarter results, as listed by Simply Wall St.

Comparison with peers

Glaukos (NYSE, USD): minus 1.20 percent, price-to-earnings ratio -51.10, market capitalization USD 9.8 billion
Alcon (NYSE, USD): plus 4.24 percent, price-to-earnings ratio 51.16, market capitalization USD 32.2 billion
The Cooper Companies (NYSE, USD): plus 4.61 percent, price-to-earnings ratio 19.57, market capitalization USD 10.9 billion

Trading view for investors

The market picture combines a dated analyst target with a wide annual range and a scheduled results date. The next report on October 28, 2026 will provide the next company-specific checkpoint for revenue growth, operating losses and product adoption. For now, the key distinction is between the euro indication and the US listing: the former stood at EUR 148.50 at Lang & Schwarz, while the latter was USD 165.87 on the NYSE.

The further course of trading is shown by the continuously updated real-time quote of Glaukos stock.

Glaukos stock at a glance

  • Company: Glaukos Corporation
  • ISIN: US3773221029
  • Ticker: GKOS
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 15, 2026, 9:48 p.m. CEST): EUR 148.50
  • NYSE quote (as of October 15, 2026, 3:59 p.m. ET): USD 165.87
  • NYSE daily change: minus 1.20 percent
  • Market capitalization: USD 9.8 billion (as of October 15, 2026)
  • 52-week range: USD 73.16-191.62 (as of October 15, 2026)
  • Sector / Industry: Healthcare / Medical Devices
  • Next earnings date: October 28, 2026

Market context: Market report S&P 500.

More news and analyses on Glaukos stock

Disclaimer...
en | US3773221029 | GKOS | boerse | 70333107 | bgmi